Insiders / Loewy Caroline M
Loewy Caroline M
CIK 1367451personinsider
Companies
6
First seen
Jan 6, 2021
Last activity
Jun 13, 2024
Companies
| Company | Shares held | Latest |
|---|---|---|
| eFFECTOR Therapeutics, Inc. · EFTR | 9,047 | — |
| Phoenix Biotech Acquisition Corp. · CERO | 5,828 | — |
| PhaseBio Pharmaceuticals Inc · PHAS | 3,750 | — |
| Aptose Biosciences Inc. · APTO | — | — |
| CymaBay Therapeutics, Inc. · CBAY | — | — |
| Zogenix, Inc. · ZGNX | — | — |
All securities held
8 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| eFFECTOR Therapeutics, Inc. | Common stock | 9,047 |
| eFFECTOR Therapeutics, Inc. | Class B common stock | 17,500 |
| PhaseBio Pharmaceuticals Inc | Common stock | 3,750 |
| Phoenix Biotech Acquisition Corp. | Class A common stock | 5,828 |
| Phoenix Biotech Acquisition Corp. | Class B common stock | 17,500 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Aptose Biosciences Inc. | Options | 50,000 |
| eFFECTOR Therapeutics, Inc. | Options | 800 |
| PhaseBio Pharmaceuticals Inc | Options | 17,500 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 27, 2021 | Grant Grant or award | ZGNX Zogenix, Inc. Stock Option (Right to Buy) | — | +22K | 22,000 | low |
| Jun 3, 2021 | Grant Grant or award | PHAS PhaseBio Pharmaceuticals Inc Non-employee Director Stock Option (right to buy) | — | +14K | 14,000 | low |
| Oct 8, 2021 | Other Other (per filing) | CERO Phoenix Biotech Acquisition Corp. Class B Common Stock | — | +18K | 17,500 0.04% of shares |